Development and testing of a digitally assisted risk reduction platform for youth at high risk for suicide

Active Project Grant Awarded Last action

Award ID
R44MH128484
Recipient
Awarding agency
Obligated
$11,246,327

Award facts

Assistance listing
93.242 Mental Health Research Grants
Completion date 96% complete
Originally
Funding
  • $10,099,158.00 Federal
  • $1,147,169.00 Non-federal
Place of performance
Eugene, OR, USA

Award details come from USAspending.gov.

Description

Abstract
Despite efforts to prevent suicide, US rates are climbing, and suicide is the second leading cause of death amongst youth. Although promising approaches are available for preventative interventions with youth at-risk for suicide, they demonstrate modest benefit, and recent reviews have concluded that new developments are required that facilitate not only greater effectiveness, but also enhance treatment engagement, adherence, and continuity of care amongst these young people. Digital tools, especially personal smartphones, are promising avenues to address these issues and can be used to provide a unique understanding of proximal risk factors, including psychological distress, anhedonia and behavioral withdrawal, and sleep disturbance amongst high- risk individuals. Furthermore, digital methods can provide ongoing supportive patient contact to support the reduction of suicide risk. The overall aim of this fast-track sbir proposal is to enhance the effectiveness of selective and indicated prevention for youth who are received outpatient mental health care by developing and testing a comprehensive digital platform that allows practitioners to integrate objective mobile sensing and hipaa compliant client communication tools into their management of these young people. We have developed an initial MVP version of these products, and in phase i will utilize user-centered design principles to enhance the product fit with typical service delivery systems found in healthcare organizations working with high-risk individuals (i.e., intensive outpatient services). The aim of phase II is to further optimize these products and conduct a pragmatic clinical trial of the effectiveness, feasibility, and acceptability of the products in a real world intensive outpatient clinical service. We will utilize the data generated by this trial to improve adoption, implementation fidelity, and sustained use of these tools, guided by an implementation science framework.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $794,102 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $50,000 $0
Amendment $50,000 $0
Amendment $50,000 $0
Amendment -$5,052 $0
Amendment $5,052 $0
Amendment -$5,052 $0
Amendment $5,052 $0
Amendment -$5,052 $0
Amendment $5,052 $0
Amendment $818,819 $0
Amendment $818,819 $0
Amendment $818,819 $0
Amendment $818,819 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $93,124 $93,124
Amendment $93,124 $0
Amendment $93,124 $0
Amendment $93,124 $0
Amendment $93,124 $0
Amendment $750,675 $0
Amendment $750,675 $750,675
Amendment $750,675 $0
Amendment $750,675 $0
Amendment $750,675 $0
Amendment $750,675 $0
Amendment $303,370 $0
Amendment $303,370 $303,370
Original award $303,370 $0
Show all 41

Quick answers

Who received award R44MH128484?

R44MH128484 was awarded to Ksana Health Inc. by National Institute of Mental Health (National Institutes of Health) on September 1, 2022.

How much is award R44MH128484 worth?

$11,246,327 has been obligated on R44MH128484: $10,099,158 in federal funding and $1,147,169 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award